Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > TGF-alpha

TGF-alpha

Brief Information

Name:Transforming growth factor alpha
Target Synonym:TGFA,TFGA,Transforming Growth Factor alpha,TGF type 1,EGF-like TGF,ETGF,TGF-Alpha,Transforming Growth Factor, Alpha,Protransforming Growth Factor Alpha
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
TGA-H5119 Human Human Transforming growth factor-alpha / TGF-alpha Protein, premium grade
TGA-H5119-structure
TGA-H5119-sds
TGA-H5119-hplc
ACRO Quality

Part of Bioactivity data

TGA-H5119-Cell-based assay
 TGF-alpha CELL

Human TGF-αlphα Protein, premium grade (Cat. No. TGA-H5119) induced Human EGF R (Luc) HEK293 Reporter Cell. The EC50 for this effect is 4.606 ng/mL (Routinely tested).

TGA-H5119-ELISA
 TGF-alpha ELISA

Immobilized Human TGF-alpha Protein, premium grade (Cat. No. TGA-H5119) at 2 μg/mL (100 μL/well) can bind Biotinylated Human EGF R, Fc,Avitag (Cat. No. EGR-H82F8) with a linear range of 0.3-39 ng/mL (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Fepixnebart LY-3016859 Phase 2 Clinical Eli Lilly And Company Diabetic Neuropathies; Osteoarthritis, Knee; Diabetic Nephropathies; Osteoarthritis; Low Back Pain Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message